Acadia Pharmaceuticals (ACAD) Reports Q3 Loss of $0.42, Beats by 3c
More News related to ACAD
- Acadia Pharmaceuticals (ACAD) Tops Q3 EPS by 1c
- ACADIA Pharmaceuticals Reports Third Quarter 2009 Financial Results
- ACADIA Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 9, 2009
- ACADIA Pharmaceuticals to Present at the BIOCOM Investor Conference on October 26, 2009
- ACADIA Pharma (ACAD) to Cut Workforce by 50%
More News related to Earnings
- Ocean Bio-Chem (OBCI) Posts Q3 EPS of $0.07, Lower Y/Y by 1c; Revs Higher
- Highlights From CLWR's Q3 Conference Call: Funding Initiative A Go!, But Investors Worry About Long-Term Outlook
- Arden Group (ARDNA) Posts Q3 EPS of $1.48, Beats Q308 by 18c
- Macy's (M) Shows Good Progress, But Not Good Enough
- Universal Security (UUU) Share Trade Higher on Q2 Earnings Report
Acadia Pharmaceuticals (Nasdaq: ACAD) reports Q3 loss of $0.42, 3 cents better than the analyst estimate of ($0.45). Revenue for the quarter was $282K, versus the consensus of $1.05 million.
Related Categories
EarningsStocks Mentioned
-0.10Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
